The automated cybersecurity software provider, which counts SB Isat as an investor, had been reported to be seeking a $5bn valuation for its flotation.

Samsung Next and Assurant were among the investors in the $53.5m equity portion of a $71.4m round led by JMS Capital-Everglen.

Evotec has partnered Bristol-Myers Squibb to launch a $20m commercialisation programme aimed at academic institutions in Germany’s Rhine-Main-Neckar region.

Osage University Partners was among the investors in the cybersecurity training services provider’s series A round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Alphabet, Tencent and Gilead Sciences are in line to achieve exits, after the vaccine developer filed to go public on the Nasdaq Global Market.

Autobio Diagnostics is set to exit the molecular diagnostic test provider through a purchase by women’s health-focused technology provider Hologic.

Schroder UK Public Private Trust, the rebranded fund previously led by Neil Woodford, has sold its shareholding in Carrick Therapeutics at a discount.

University of Oxford, OSI and Parkwalk Advisors all returned for Oxford Endovascular’s $10m series A round.

Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.